Nida Khan in TCS Nashik case: Designation disputed, pregnancy cited for bail, police deploy four teams in ongoing manhunt
Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Gilead Sciences, Second Genome form IBD drug discovery alliance Gilead Sciences has entered into a four-year deal worth up to $338 million with California-based clinical-stage company Second… bypharmanewsdailyApril 9, 2020
